+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 11



Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 11



International Journal of Pharmaceutical Compounding 13(1): 56-62



Total patient care necessitates the use of hazardous drugs in the compounding of preparations. With approximately 5.5 million U.S. healthcare workers potentially being exposed to hazardous drugs, the importance and necessity of a pharmacy establishing and maintaining standard operating procedures pertaining to the handling of hazardous drugs cannot be minimized. This article defines hazardous drugs, discusses many of the factors that impact worker exposure, identifies many of the sources of exposure, identifies the four general goals for handling hazardous drugs, discusses the proper handling and disposal of hazardous drug waste materials, and provides a checklist that can be used by a pharmacy to establish protocols for a hazardous drug program.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 051761086

Download citation: RISBibTeXText

PMID: 23969965


Related references

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 18: verification of automated compounding devices for parenteral nutrition compounding and finished preparation release checks and tests. International Journal of Pharmaceutical Compounding 14(2): 142-149, 2010

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 12. International Journal of Pharmaceutical Compounding 13(2): 146-150, 2009

Basics of compounding; considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 13. International Journal of Pharmaceutical Compounding 13(3): 234-238, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding sterile preparations, part 6: 2008 revisions to chapter 797. International Journal of Pharmaceutical Compounding 12(2): 136-144, 2008

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 8: stability and beyond-use dating. International Journal of Pharmaceutical Compounding 12(4): 344-353, 2008

Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2. International Journal of Pharmaceutical Compounding 11(4): 313-323, 2007

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics. International Journal of Pharmaceutical Compounding 11(6): 492-499, 2007

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 15: personnel training, cleansing, and garbing. International Journal of Pharmaceutical Compounding 11(5): 420-426, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 16: suggested standard operating procedures. International Journal of Pharmaceutical Compounding 13(6): 546-553, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 14: environmental quality and control (continued). International Journal of Pharmaceutical Compounding 13(4): 322-329, 2009

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 7: microbial contamination risk levels, 12-hour use, and immediate use. International Journal of Pharmaceutical Compounding 12(3): 252-257, 2008

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 20: patient or caregiver training, patient monitoring and adverse events reporting, and quality-assurance program. International Journal of Pharmaceutical Compounding 14(4): 328-331, 2010

Basics of compounding: implementing United States pharmacopeia chapter <795> pharmaceutical compounding--nonsterile preparations, part 4. International Journal of Pharmaceutical Compounding 16(1): 64-68, 2012

Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 9: immediate use compounded sterile preparations. International Journal of Pharmaceutical Compounding 12(5): 440-443, 2008

Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 5: verification of accuracy, sterility, and sterilization of compounded preparations. International Journal of Pharmaceutical Compounding 12(1): 54-60, 2008